NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (AMEX:NBS), a leading-edge healthcare services company seeking to capitalize on existing treatments and future breakthroughs in the burgeoning field of adult stem cell therapeutics, today announced the signing of an agreement with Stem Collect LLC, to open a Beverly Hills location, pursuant to a multi-territory development agreement between the parties. Stem Collect’s Chairman is James R. Doty, MD, the former CEO of Accuray, (NASDAQ:ARAY). NeoStem is particularly enthusiastic about opening a center in the Beverly Hills area because of its population focused on health, fitness and longevity. Finalization of the site is underway and will be opened upon build-out and satisfaction of licensing requirements.
